Visiongain has launched a new pharma report Global Biosimilars and Follow-On Biologics Market : Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones.

Many companies are chasing development of the same biosimilar targets, which could lead to heavily fragmented markets if multiple therapies are approved. Although this occurs in the small molecule generics market, it will prove to be more of a challenge for biosimilars. There developers need to receive sufficient uptake to recoup the high development and manufacturing costs of biosimilars.

Uptake of biosimilars varies greatly between different regions, and marketing and education campaigns will be needed to combat this and convince consumers, doctors and healthcare payers of the benefits of biosimilars.

The lead analyst of the report commented "Growth will be restrained in the biosimilar growth hormones submarket by steady uptake for branded therapies, high brand loyalty, as well as the launch of long-acting growth hormones. Rising diabetes incidence will drive demand for biosimilar human insulin in emerging markets, while the launch of biosimilar insulin glargine in developed markets during the forecast period will drive growth in the biosimilar insulin analogues sector."

Leading companies featured in the report include Biocon Limited, Biogen Idec Inc., Bioton, Celltrion Pharm, Inc., Dong-A Pharmaceutical Co., Ltd., Dr.Reddy's Labs (DRL), Genentech (Roche Group), Hexal AG, Hospira, Intas Pharmaceuticals Ltd., LG Life Sciences and others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.